NCT07121140Recruiting
Home Blood Transfusions
A Pilot Study of Home Blood Transfusions for Patient With Cancer Who Have Transfusion Dependent Cytopenias
Source: ClinicalTrials.gov · Last updated 16 Dec 2025
Brief summary (registry, in English)
This is a pilot single arm study to evaluate the feasibility and acceptability of a home blood transfusion program. Patients will be enrolled with hematologic malignancies and other bone marrow failure syndromes who are transfusion dependent and interested in a home blood transfusion program. Participants enrolled in the study will receive 1-5 units of blood products at home. Data on barriers to administration will be recorded. Surveys and qualitative interviews will be completed to better understand acceptability of the program.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 30 Jul 2025
- Start date
- 3 Jun 2025
- Primary completion date
- Jun 2027
- Lead sponsor
- Thomas Jefferson University
- NCT number
- NCT07121140
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 3 Jun 2025 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients who have a history of a transfusion reaction
- Heart failure as defined by AHA stage C or NYHA Class II-IV
- Diagnosis of Solid Tumor malignancy
Other
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Non-English or Spanish speaking
- Are unhoused
- Are incarcerated
- Have poor venous access
- Women who are pregnant
Who the study is looking for
- Individuals must meet all of the following inclusion criteria in order to be eligible to participate in the study:
- Provide signed and dated informed consent form Willing to comply with all study procedures and be available for the duration of the study
- Male or female, over the age of 18
- Must meet definition of transfusion dependence (require at least 2 blood product transfusions over a 28-day period)
- Receive their cancer care at SKCCC
- Have a history of blood product transfusions and NO history of transfusion reactions,
- Live within a 30-mile range of the Center City SKCCC location.
- Must be willing to allow people into the home
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Thomas Jefferson University Hospital Coordinator of this site? Confirm its status | Philadelphia | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.